Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

The supplement significantly improves hair density and appearance in people with hair loss.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Erosive pustular dermatosis in elderly people may be linked to aging immune systems and skin damage.

Treatment with methotrexate and prednisolone led to complete hair regrowth and no relapse for 2 years.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

Environmental pollutants can damage hair health and cause hair loss.

ECM-inspired wound dressings can help heal chronic wounds by controlling macrophage activity.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Patients with metabolic syndrome often have skin problems like acanthosis nigricans and skin tags, and early treatment is important to prevent serious issues.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

Iron deficiency common in women, not always linked to hair loss; more research needed.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.